RedHill Biopharma reported 0.04 in PE Price to Earnings for its fiscal quarter ending in June of 2025.





Pe Change Date
Cara Therapeutics 0.49 27.28 Mar/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.58 0.12 Jun/2026
Cronos Group 283.6 162.67 Jun/2026
RedHill Biopharma 0.04 0.03 Jun/2025